PFIZER INC.
- Country
- ๐บ๐ธUnited States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
- First Posted Date
- 2024-09-27
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 200
- Registration Number
- NCT06616194
- Locations
- ๐ฏ๐ต
Tominaga Clinic, Osaka-Shi, Osaka, Japan
๐บ๐ธWasatch Clinical Research, LLC, Salt Lake City, Utah, United States
๐บ๐ธGranger Medical Holladay - Holladay Clinic, Salt Lake City, Utah, United States
Korean Post Marketing Surveillance for Comirnaty Injection (Bretovameran)
- First Posted Date
- 2024-09-26
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 660
- Registration Number
- NCT06613984
- Locations
- ๐ฐ๐ท
Pfizer Korea, Seoul, Korea, Republic of
A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma as Compared With Standard of Care Therapies
- Conditions
- Interventions
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1
- Registration Number
- NCT06592222
- Locations
- ๐บ๐ธ
Pfizer, New York, New York, United States
A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Older Adults in Korea
- Conditions
- Interventions
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 360
- Registration Number
- NCT06593587
- Locations
- ๐ฐ๐ท
The Catholic Univ. of Korea Seoul St. Mary's Hospital, Seoul, Seoul-teukbyeolsi [seoul], Korea, Republic of
๐ฐ๐ทInha University Hospital, Incheon, Incheon-gwangyeoksi [incheon], Korea, Republic of
๐ฐ๐ทJeonbuk National University Hospital, Jeonju-si, Jeonrabugdo, Korea, Republic of
To Learn How Different Forms of Study Medicine Are Taken up Into the Blood and the Effect of Food on Study Medicine in Healthy Adults
- Conditions
- Interventions
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 13
- Registration Number
- NCT06593054
- Locations
- ๐ง๐ช
Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Rรฉgion DE, Belgium
๐ง๐ชPfizer Clinical Research Unit, Brussels, Belgium
A Study to Learn How Renal Impairment Affects the Pharmacokinetics of PF-07817883.
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 28
- Registration Number
- NCT06586216
- Locations
- ๐บ๐ธ
Clinical Pharmacology of Miami, Miami, Florida, United States
๐บ๐ธGenesis Clinical Research, LLC, Tampa, Florida, United States
๐บ๐ธPrism Research LLC dba Nucleus Network, Saint Paul, Minnesota, United States
A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 100
- Registration Number
- NCT06587035
Korean Post Marketing Surveillance for ELREXFIO (Elranatamab).
- First Posted Date
- 2024-09-03
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 150
- Registration Number
- NCT06581848
- Locations
- ๐ฐ๐ท
Pfizer Korea, Seoul, Korea, Republic of
A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer
- Conditions
- Interventions
- First Posted Date
- 2024-08-30
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 190
- Registration Number
- NCT06580938
- Locations
- ๐บ๐ธ
START Midwest, Grand Rapids, Michigan, United States
๐บ๐ธHighlands Oncology Group, Springdale, Arkansas, United States
A Study to Learn How Different Amounts of the Study Medicine Danuglipron Are Taken up Into the Blood in Otherwise Healthy Adults With Overweight or Obesity
- First Posted Date
- 2024-08-23
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 23
- Registration Number
- NCT06568731
- Locations
- ๐บ๐ธ
Pfizer Clinical Research Unit - New Haven, New Haven, Connecticut, United States